Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019048703) USE OF SCLERITINE AS AGENT FOR PROTECTING CELLS AGAINST TOXIC AGENTS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/048703 International Application No.: PCT/EP2018/074455
Publication Date: 14.03.2019 International Filing Date: 11.09.2018
IPC:
A61K 38/17 (2006.01) ,A61K 8/64 (2006.01) ,A61Q 17/00 (2006.01) ,A61P 39/00 (2006.01) ,A61P 17/16 (2006.01) ,A61P 17/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8
Cosmetics or similar toilet preparations
18
characterised by the composition
30
containing organic compounds
64
Proteins; Peptides; Derivatives or degradation products thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
Q
SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
17
Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
39
General protective or antinoxious agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17
Drugs for dermatological disorders
16
Emollients or protectives, e.g. against radiation
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17
Drugs for dermatological disorders
Applicants:
CENTRE SCIENTIFIQUE DE MONACO [MC/MC]; 8 Quai Antoine 1er 98000 MONACO, MC
SQY THERAPEUTICS [FR/FR]; 50 Allée de Chaponval 78590 NOISY-LE-ROI, FR
Inventors:
BENCHAOUIR, Rachid; FR
BUCLEZ, Pierre-Olivier; FR
Agent:
HAUTIER IP; 1, rue du Gabian - Le Thalès 98000 MONACO, MC
Priority Data:
17 5834711.09.2017FR
Title (EN) USE OF SCLERITINE AS AGENT FOR PROTECTING CELLS AGAINST TOXIC AGENTS
(FR) UTILISATION DE LA SCLÉRITINE EN TANT QU'AGENT PROTECTEUR DE CELLULES CONTRE DES AGENTS TOXIQUES
Abstract:
(EN) The invention relates to the use of Scleritine as an agent for protecting cells against toxic agents, including in particular chemical agents or physical agents. The invention relates to a dermatological and/or cosmetic composition for the skin which protects against toxic agents, characterized in that it comprises Scleritine in at least one excipient or carrier suitable for topical application. The field of the invention relates to the pharmaceutical industry or the cosmetics industry and more specifically for the formulation of pharmaceutical or cosmetic compositions intended for protecting cells against toxic agents.
(FR) L'invention concerne l'utilisation de la Scléritine en tant qu'agent protecteur pour des cellules contre des agents toxiques dont notamment des agents chimiques ou des agents physiques. L'invention concerne une composition dermatologique et/ou cosmétique protectrice cutanée vis-à-vis d'agents toxiques caractérisée en ce qu'elle comprend de la Scléritine dans au moins un excipient ou véhicule adapté pour une application topique. Le domaine de l'invention concerne l'industrie pharmaceutique ou l'industrie cosmétique et plus spécifiquement pour la formulation de compositions pharmaceutiques ou cosmétiques destinées à protéger les cellules contre des agents toxiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: French (FR)
Filing Language: French (FR)